Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic Randomized Controlled Trial to Evaluate the Effect of CirrhosisRx, a Novel Clinical Decision Support System, on Guideline-adherence and Clinical Outcomes for Patients With Cirrhosis

NCT05967273 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05967273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05967273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic Randomized Controlled Trial to Evaluate the Effect of CirrhosisRx, a Novel Clinical Decision Support System, on Guideline-adherence and Clinical Outcomes for Patients With Cirrhosis
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Recruiting
Start date
January 14, 2025
Completion date
January 31, 2027
Enrollment
2,106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, decision support systems, clinical